AF647 Anti-Human CD16 Antibody[3G8]

The AF647 Anti-Human CD16 Antibody[3G8] is a highly specific and reliable tool designed for the detection and analysis of CD16 expression in human samples. This monoclonal antibody, produced by our team of experts, has been extensively validated and optimized to ensure exceptional performance in various applications, including flow cytometry, immunohistochemistry, and immunofluorescence.

CD16, also known as FcγRIII, is a low-affinity receptor for the Fc region of immunoglobulin G (IgG). It is expressed on the surface of natural killer (NK) cells, macrophages, and neutrophils, playing a crucial role in mediating antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis. The AF647 Anti-Human CD16 Antibody[3G8] specifically recognizes the extracellular domain of CD16, allowing for the precise identification and characterization of CD16-positive cells in complex biological samples.

This antibody is conjugated with AF647, a bright and photostable fluorescent dye, enabling easy and reliable detection of CD16 expression. The AF647 Anti-Human CD16 Antibody[3G8] exhibits exceptional sensitivity and specificity, ensuring accurate and reproducible results. It has been extensively tested on a wide range of human cell lines and primary cells, demonstrating excellent staining performance and minimal background signal.

The AF647 Anti-Human CD16 Antibody[3G8] is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody conjugation procedures. It is provided in a convenient format, allowing for easy integration into existing laboratory protocols. Each batch of this antibody undergoes rigorous quality control measures to ensure consistent performance and reliability.

In summary, the AF647 Anti-Human CD16 Antibody[3G8] is a highly specific and reliable tool for the detection and analysis of CD16 expression in human samples. With its exceptional sensitivity, specificity, and ease of use, this antibody is an invaluable asset for researchers and clinicians studying immune cell function, cancer immunotherapy, and autoimmune diseases.